FDA Inspection 1257321 — Chartwell Pharmaceuticals Congers, LLC
The FDA completed an inspection of Chartwell Pharmaceuticals Congers, LLC on Dec 19, 2024 in Congers, NY. The inspection was classified OAI (Official Action Indicated — regulatory and/or administrative actions are recommended). Product area: Drugs.
Inspection Details
- Classification
- Official Action Indicated (OAI)
- End Date
- Dec 19, 2024
- Fiscal Year
- 2025
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Congers, NY (United States)